Mesa Laboratories (MLAB)

• Market cap: $717M
• 1 day: 0.52%
• 5 days: 3.78%
• 1 month: 33.97%
• 3 months: 2.73%
• 6 months: 44.03%
• Year to date: 24.30%
• 1 year: 29.24%
• 5 years: -46.93%
• 10 years: 73.84%
• Sector: Industrials
• Industry: Industrial Instruments for Measurement, Display, and Control

About: Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Employees: 736

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 20

42% more capital invested

Capital invested by funds: $445M [Q2] → $634M (+$188M) [Q3]

6% more funds holding

Funds holding: 154 [Q2] → 164 (+10) [Q3]

8% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 51

4.73% less ownership

Funds ownership: 95.17% [Q2] → 90.44% (-4.73%) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $160 21% upside
• Avg. target: $160 21% upside
• High target: $160 21% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Evercore ISI Group Vijay Kumar 60% 1-year accuracy 28 / 47 met price target

21% upside $160

Outperform Maintained

1 Oct 2024